Status:
RECRUITING
A Predictive Model for Recurrence of Colorectal Cancer Based on Multi-omics of Portal Vein Blood
Lead Sponsor:
Peking University Shougang Hospital
Collaborating Sponsors:
Beijing Tiantan Hospital
Peking University Third Hospital
Conditions:
Colorectal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This multi-center study aims to develop a precise predictive model for colorectal cancer (CRC) recurrence and metastasis based on multi-omics analysis of portal vein blood. Despite advances in surgica...
Detailed Description
1. Study Title A predictive model for recurrence of colorectal cancer based on multi-omics of portal vein blood: a multi-center study 2. Study Overview This multicenter study, led by Peking University...
Eligibility Criteria
Inclusion
- Age 18 years or older
- Histologically confirmed stage I-IV colorectal cancer (CRC)
- Availability of pre-operative and intra-operative blood samples (portal vein and peripheral blood) and primary tumor tissue samples
- No neoadjuvant therapy before surgery
Exclusion
- Prior history of other malignancies
- Incomplete clinical information or pathology reports
- Incomplete follow-up records
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT06524245
Start Date
January 1 2020
End Date
December 1 2026
Last Update
July 31 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University Shougang Hospital
Beijing, Beijing Municipality, China, 100144